About RR Pharmaceuticals
RR Pharmaceuticals is a company based in Delhi (India) founded in 2012. It operates as a B2B. RR Pharmaceuticals offers products and services including Azacitidine for Injection, Ritonavir Tablets, Docetaxel Injection, Lopinavir and Ritonavir Tablets, and Capecitabine Tablets. RR Pharmaceuticals operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
- Headquarter Delhi, India
- SectorsHealthcare
- Website rrpharmaceuticals.in
- Legal Name Rr Pharmaceuticals Private Limited
- Date of Incorporation 01 Aug, 2012
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹19.98 Cr
FY 2025 · -29% YoY
- Net Loss-₹25.8 Lakh
FY 2025 · -1% margin
- EBITDA₹29.9 Lakh
FY 2025 · 1% margin
Associated legal entities of RR Pharmaceuticals
RR Pharmaceuticals operates through Rr Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rr Pharmaceuticals Private Limited CIN U24232DL2012PTC239707 | Active | 01 Aug 2012 | New Delhi, Delhi | ₹20.0 Cr | – | 3 | View details |
Products & Services of RR Pharmaceuticals
RR Pharmaceuticals offers a comprehensive portfolio of products and services, including Azacitidine for Injection, Ritonavir Tablets, Docetaxel Injection, Lopinavir and Ritonavir Tablets, and Capecitabine Tablets.
Injection used for treating myelodysplastic syndrome and leukemia.
Antiviral tablet for managing HIV infections effectively.
Chemotherapy injection for breast and prostate cancer treatment.
Combined tablet for HIV therapy and viral load reduction.
Oral medication for metastatic breast and colorectal cancers.
Capsule to suppress HIV replication in infected patients.
Tablet for treating chronic myeloid leukemia and tumors.
Injection therapy for lung cancer and mesothelioma cases.
Board of directors of Rr Pharmaceuticals Private Limited (RR Pharmaceuticals)
Rr Pharmaceuticals Private Limited is the primary company behind RR Pharmaceuticals. The board of Rr Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Kanchan Kumar, appointed in 2012. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kanchan Kumar DIN 00449902 | Director | 01 Aug 2012 | 14 yrs 2 mo | Rr Pharmaceuticals Private Limited |
| Pramod Kumar DIN 00449846 | Managing Director | 01 Aug 2012 | 14 yrs 2 mo | Rr Pharmaceuticals Private Limited |
| Rachit Kumar DIN 06881490 | Director | 26 May 2014 | 12 yrs 4 mo | Rr Pharmaceuticals Private Limited |
Financials of RR Pharmaceuticals
Figures of Rr Pharmaceuticals Private Limited, the primary company behind RR Pharmaceuticals, for FY 2025. Revenue was ₹19.98 Cr (-29% year on year). Net loss was -₹25.8 Lakh (-1% margin). EBITDA was ₹29.9 Lakh (1% margin). Revenue has grown at a compounded annual rate of +28% over three years and +15% over five years.
- ₹19.98 CrRevenue · FY 2025 · -29% YoY
- -₹25.8 LakhNet loss · -1% margin
- ₹29.9 LakhEBITDA · 1% margin
- ₹5 LakhPaid-up capital
- +28%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rr Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for RR Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of RR Pharmaceuticals
RR Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $11.53M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| mahaveermedi.com | 2016 | Bengaluru, India | – | 588 | Serves as a distributor of a wide range of pharmaceutical drugs. | |
| dipnapharmachem.com | 2011 | Ahmedabad, India | – | – | Distributor of pharmaceutical raw materials |
Detailed competitors of RR Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to RR Pharmaceuticals
10 companies that operate in the same segment as RR Pharmaceuticals (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RR Pharmaceuticals
RR Pharmaceuticals was founded in 2012.
RR Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind RR Pharmaceuticals, Rr Pharmaceuticals Private Limited, reported revenue of ₹19.98 Cr for FY 2025, down 29% year on year.
RR Pharmaceuticals specializes in distributing pharmaceutical products, including oncology injectables and solid orals, as well as ARV medications. With over 35 years of experience, they offer customized logistics solutions, warehousing, and transportation services to businesses worldwide. Based in New Delhi, India, they ensure efficient delivery and real-time tracking, serving clients from startups to large corporations with a focus on quality and reliability.
RR Pharmaceuticals's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
RR Pharmaceuticals offers Azacitidine for Injection, Ritonavir Tablets, Docetaxel Injection, Lopinavir and Ritonavir Tablets, and 4 more products and services.
RR Pharmaceuticals operates through Rr Pharmaceuticals Private Limited.
The legal entities of RR Pharmaceuticals currently have 3 directors, including Rachit Kumar, Kanchan Kumar, Pramod Kumar.